The diabetes drug Byetta was linked to four more deaths in patients with pancreatitis, adding to two deaths announced by federal regulators last week.

Federal regulators are working on a stronger label for a widely used diabetes drug, Byetta, after deaths continue to be reported despite earlier government warnings.